ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.53
0.00%
US Tech 100
17,612.00
0.01%
S&P 500
5,180.74
0.00%
US Dollar vs CAD
1.36731
0.01%
Bitcoin
63,533.80
0.58%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Innate Pharma SA (IPHA)

  7. Innate Pharma SA (IPHA) News

IPHA

Innate Pharma (IPHA)

Innate Pharma SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPHA
DateTimeSourceHeadlineSymbolCompany
05/07/202412:00AMBusiness WireInnate Pharma Announces Conference Call and Webcast for Q1 2024 Business UpdateNASDAQ:IPHAInnate Pharma SA
05/07/202412:00AMBusiness WireInnate Pharma organise une conférence téléphonique pour présenter ses résultats au premier trimestre 2024NASDAQ:IPHAInnate Pharma SA
04/15/202412:00AMBusiness WireInnate Pharma annonce la progression de l’essai clinique évaluant le NK Cell Engager SAR443579 / IPH6101 développé par Sanofi vers la Phase 2 dans divers cancers du sangNASDAQ:IPHAInnate Pharma SA
04/15/202412:00AMBusiness WireInnate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer PatientsNASDAQ:IPHAInnate Pharma SA
04/15/202412:00AMBusiness WireL’Assemblée Générale d’Innate Pharma aura lieu le 23 mai 2024NASDAQ:IPHAInnate Pharma SA
04/15/202412:00AMBusiness WireInnate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024NASDAQ:IPHAInnate Pharma SA
04/10/202412:00AMBusiness WireInnate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug ConjugateNASDAQ:IPHAInnate Pharma SA
04/10/202412:00AMBusiness WireInnate Pharma présente des données d’efficacité précliniques pour IPH45, son conjugué anticorps-médicament innovant ciblant nectine-4 a l’AACR 2024NASDAQ:IPHAInnate Pharma SA
04/09/202412:00AMBusiness WireInnate Pharma annonce sa participation à une prochaine Conférence InvestisseursNASDAQ:IPHAInnate Pharma SA
04/09/202412:00AMBusiness WireInnate Pharma Announces Its Participation in Upcoming Investor ConferenceNASDAQ:IPHAInnate Pharma SA
04/05/20242:34AMBusiness WireInnate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-FNASDAQ:IPHAInnate Pharma SA
04/05/20242:34AMBusiness WireInnate Pharma publie son Document D’enregistrement Universel 2023 et son Rapport Annuel 2023 sur « Form 20-F »NASDAQ:IPHAInnate Pharma SA
03/21/20241:00AMBusiness WireInnate Pharma présente ses résultats financiers et l'avancée de son portefeuille pour l'année 2023NASDAQ:IPHAInnate Pharma SA
03/21/20241:00AMBusiness WireInnate Pharma Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:IPHAInnate Pharma SA
03/19/20241:00AMBusiness WireInnate Pharma Announces Its Participation to Upcoming Investor ConferenceNASDAQ:IPHAInnate Pharma SA
03/19/20241:00AMBusiness WireInnate Pharma annonce sa participation à une prochaine conférence investisseursNASDAQ:IPHAInnate Pharma SA
03/14/20241:00AMBusiness WireInnate Pharma organise une conférence téléphonique et un webcast pour présenter ses résultats financiers 2023NASDAQ:IPHAInnate Pharma SA
03/14/20241:00AMBusiness WireInnate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial ResultsNASDAQ:IPHAInnate Pharma SA
03/06/202412:00AMBusiness WireInnate Pharma présentera des données précliniques concernant son anticorps conjugué IPH45 ciblant Nectine-4 à l’AACR 2024NASDAQ:IPHAInnate Pharma SA
03/06/202412:00AMBusiness WireINNATE PHARMA: TRAITEMENT DU PREMIER PATIENT DANS L’ESSAI DE PHASE 1/2 EVALUANT IPH6501 DANS LES LYMPHOMES NON HODGKINIENS A LYMPHOCYTES B EN RECHUTE ET/OU REFRACTAIRESNASDAQ:IPHAInnate Pharma SA
03/06/202412:00AMBusiness WireInnate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024NASDAQ:IPHAInnate Pharma SA
03/06/202412:00AMBusiness WireInnate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s LymphomaNASDAQ:IPHAInnate Pharma SA
02/21/202412:00AMBusiness WireInnate Pharma annonce sa participation a une prochaine conférence investisseursNASDAQ:IPHAInnate Pharma SA
02/21/202412:00AMBusiness WireInnate Pharma Announces Its Participation to Upcoming Investor ConferenceNASDAQ:IPHAInnate Pharma SA
01/16/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IPHAInnate Pharma SA
01/12/20245:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IPHAInnate Pharma SA
01/12/202412:00AMBusiness WireNouveau nombre d’actions et de droits de vote d’Innate Pharma au 1er janvier 2024NASDAQ:IPHAInnate Pharma SA
01/12/202412:00AMBusiness WireNumber of Shares and Voting Rights of Innate Pharma as of January 1, 2024NASDAQ:IPHAInnate Pharma SA
01/05/20245:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IPHAInnate Pharma SA
01/04/20245:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IPHAInnate Pharma SA
 Showing the most relevant articles for your search:NASDAQ:IPHA

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
AXXA
Exxe (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
INKW
Greene Concepts (PK)
USOTC
MIKP
Mike The Pike Productions (CE)
USOTC
SFLM
SFLMaven (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
AHRO
Authentic (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
MULN
Mullen Automotive
USOTC
ENZC
Enzolytics (PK)
USOTC
ILST
International Star (PK)
USOTC
ALYI
Alternet Systems (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
XALL
Xalles (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved